Direct detection of redox active analytes |
(e.g., serotonin, epinephrine, norepinephrine, serotonin, dopamine)
|
|
Potential‐based measurements |
|
|
Current‐based measurement |
|
Use of enzyme BREs to detect byproduct of catalytic conversion of biomarkers
Need of compensations for the salinity, pH, or temperature for accurate measurement
|
Impedimetric measurements |
|
Use of immunoprecipitation BREs (e.g., protein, antibody)
Challenges with reliable biofunctionalization, thermal stability, and shelf‐life
|
Direct detection of noninvasive physical biomarkers |
|
Measured by several conventional electrical, thermal, mechanical, optical, or fluidic sensing principles
|